Craft

Nutra Pharma

Stock Price

$0

2024-10-29

Market Capitalization

$759.7 K

2024-10-29

Revenue

$246.3 K

FY, 2024

Nutra Pharma Summary

Company Summary

Overview
Nutra Pharma is a company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies. It focuses on neurological disorders, cancer, autoimmune and infectious diseases, including multiple sclerosis (MS), human immunodeficiency virus (HIV), and adrenomyeloneuropathy (AMN).
Type
Public
Status
Active
Founded
2000
HQ
Plantation, FL, US | view all locations
Website
https://www.nutrapharma.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Plantation, FL HQ

    United States

    1537 NW 65th Ave

Nutra Pharma Financials

Summary Financials

Revenue (Q3, 2025)
$70.2K
Gross profit (Q3, 2025)
$64.6K
Net income (Q3, 2025)
($523.5K)
Cash (Q3, 2025)
$3.6K
EBIT (Q3, 2025)
($356.1K)
Enterprise value
$10.7M

Footer menu